The Mystique of Hepatic Tolerogenicity

ABSTRACT

The evolution of clinical transplantation has hinged on 2 seminal turning points. The first was the demonstration in 1953 by Billingham, Brent, and Medawar that chimerism-associated tolerance could be induced deliberately in neonatal mice by infusing adult donor hematolymphopoietic cells. This discovery escalated in a straight line over the next 15 years to successful bone marrow transplantation in humans. The second turning point was the demonstration that organ allografts could self-induce tolerance under an umbrella of immunosuppression, or in some species without immunosuppression. Unfortunately, it was incorrectly concluded by most immunologists and surgeons that bone marrow and organ engraftment involved different immune mechanisms. In a derivative error, it became widely believed that the tolerogenicity of the liver differed fundamentally not only from that of bone marrow but also from that of other whole organs.

These errors became dogma and were not corrected until low level donor leukocyte chimerism was found in humans and animals bearing long surviving liver, kidney, heart, and other kinds of allografts. With successful bone marrow transplantation, the trace population consisted of recipient rather than donor leukocytes. Thus, the consequences of organ and bone marrow engraftment were mirror images. From these observations, it was proposed that the engraftment of all kinds of organs as well as bone marrow cells (BMC) involved host versus graft (HVG) and graft versus host (GVH) reactions with reciprocal induction of variable degrees of specific non-reactivity (tolerance). The maintenance of the tolerance was an active and ongoing process requiring the persistence of the transplanted fragment of the donor immune system. The immune responsiveness and unresponsiveness to both organ and bone marrow allografts are thought to be governed by the migration and localization of leukocytes. The clarifying principles of transplantation immunology that have emerged from the chimerism studies are relevant to the adaptive immune response to microbial, tumor, allogeneic, and self antigens. These principles should be used to guide efforts to systematically induce tolerance to human tissues and organs, and perhaps ultimately to xenografts.

KEYWORD

immunologic tolerance - organ allograft - liver allograft - liver tolerogenicity - liver transplantation - clonal exhaustion-deletion - immune indifference

REFERENCES

• 1 Groth C G, Brent L B, Calne R Y. Historical landmarks in clinical transplantation: conclusions from the consensus conference held at the University of California, Los Angeles (UCLA).  World J Surg . 2000;  24 834-843
• 2 Starzl T E. History of clinical transplantation.  World J Surg . 2000;  24 759-782
• 3 Starzl T E, Marchioro T L, Waddell W R. The reversal of rejection in human renal hemografts with subsequent development of homograft tolerance.  Surg Gynecol Obstet . 1963;  117 385-395
• 4 Starzl T E, Ishikawa M, Putnam C W. Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction.  Transplant Proc . 1974;  6 129-139
• 5 Merrill J P, Murray J E, Harrison J H. Successful homotransplantation of the kidney between non-identical twins.  New Engl J Med . 1960;  262 1251-1260
• 6 Murray J E, Merrill J P, Dammin G J. Study of transplantation immunity after total body irradiation: clinical and experimental investigation.  Surgery . 1960;  48 272-284
• 7 Hamburger J, Vaysse J, Crosnier J. Renal homotransplantation in man after radiation of the recipient.  Am J Med . 1962;  32 854-871
• 8 Kuss R, Legrain M, Mathe G, Nedey R, Camey M. Homologous human kidney transplantation. Experience with six patients.  Postgrad Med J . 1962;  38 528-531
• 9 Mannick J A, Lochte H L, Ashley C A, Thomas E D, Ferrebee J W. A functioning kidney homotransplant in the dog.  Surgery . 1959;  46 821-828
• 10 Murray J E, Merrill J P, Harrison J H, Wilson R E, Dammin G J. Prolonged survival of human-kidney homografts by immunosuppressive drug therapy.  New Engl J Med . 1963;  268 1315-1323
• 11 Murray J E, Wilson R E, O'Connor N E. Evaluation of long-functioning human kidney transplants.  Surg Gynecol Obstet . 1967;  124 509-520
• 12 Calne R Y. Inhibition of the rejection of renal homografts in dogs by purine analogues.  Transplant Bull . 1961;  28 445-461
• 13 Calne R Y, Alexandre G PJ, Murray J E. A study of the effects of drugs in prolonging survival of homologous renal transplants in dogs.  Ann NY Acad Sci . 1962;  99 743-761
• 14 Calne R, Friend P, Moffatt S. Prope tolerance, perioperative Campath IH, and low-dose cyclosporin monotherapy in renal allograft recipients.  Lancet . 1998;  351 1701-1702
• 15 Calne R, Moffatt S D, Friend P J. Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients.  Transplantation . 1999;  68 1613-1616
• 16 Starzl T E, Demetris A J, Murase N. The lost chord: Microchimerism.  Immunol Today. 1996;  17 577-584 588
• 17 Starzl T E, Marchioro T L, Von Kaulla N K. Homotransplantation of the liver in humans.  Surg Gynecol Obstet . 1963;  117 659-676
• 18 Starzl T E, Groth C G, Brettschneider L. Orthotopic homotransplantation of the human liver.  Ann Surg . 1968;  168 392-415
• 19 Starzl T E, Marchioro T L, Hutchison D E. The clinical use of antilymphocyte globulin in renal homotransplantation.  Transplantation . 1967;  5 1100-1105
• 20 Starzl T E, Kaupp Jr A H, Brock D R, Butz Jr W G, Linman J W. Homotransplantation of multiple visceral organs.  Am J Surg . 1962;  103 219-229
• 21 Murase N, Demetris A J, Kim D G. Rejection of the multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small bowel and liver grafts.  Surgery . 1990;  108 880-889
• 22 Murase N, Demetris A J, Matsuzaki T. Long survival in rats after multivisceral versus isolated small bowel allotransplantation under FK 506.  Surgery . 1991;  110 87-98
• 23 Starzl T E, Marchioro T L, Porter K A. Factors determining short- and long-term survival after orthotopic liver homotransplantation in the dog.  Surgery . 1965;  58 131-155
• 24 Starzl T E. Efforts to Mitigate or Prevent Rejection. In: Experience in Hepatic Transplantation Philadelphia: WB Saunders 1969: 203-206
• 25 Cordier G, Garnier H, Clot J P. La greffe de foie orthotopique chez le porc.  Mem Acad Chir (Paris) . 1966;  92 799-807
• 26 Peacock J H, Terblanche J. Orthotopic homotransplantation of the liver in the pig. In: Read AE, ed. The Liver London: Butterworth 1967: 333
• 27 Calne R Y, White H JO, Yoffa D E. Observations of orthotopic liver transplantation in the pig.  Br Med J . 1967;  2 478-480
• 28 Calne R Y, White H JO, Yoffa D E. Prolonged survival of liver transplants in the pig.  Br Med J . 1967;  4 645-648
• 29 Starzl T E. Rejection in Unmodified Animals. In: Experience in Hepatic Transplantation Philadelphia: WB Saunders 1969: 184
• 30 Hunt A C. Pathology of liver transplantation in the pig. In: Read AE, ed. The Liver London: Butterworth 1967: 337
• 31 Porter K A. Pathology of the orthotopic homograft and heterograft. In: Experience in Hepatic Transplantation Starzl TE, ed. Philadelphia: WB Saunders 1969: 422-471
• 32 Billingham R E, Brent L, Medawar P B. ``Actively acquired tolerance'' of foreign cells.  Nature . 1953;  172 603-606
• 33 Billingham R, Brent L, Medawar P. Quantitative studies on tissue transplantation immunity. III. Actively acquired tolerance.  Philos Trans R Soc Lond (Biol) . 1956;  239 357-412
• 34 Main J M, Prehn R T. Successful skin homografts after the administration of high dosage X radiation and homologous bone marrow.  J Natl Cancer Inst . 1955;  15 1023-1029
• 35 Mathe G, Amiel J L, Schwarzenberg L, Cattan A, Schneider M. Haematopoietic chimera in man after allogenic (homologous) bone-marrow transplantation.  Brit Med J . 1963;  2 1633-1635
• 36 Gatti R A, Meuwissen H J, Allen H D, Hong R, Good R A. Immunological reconstitution of sex-linked lymphopenic immunological deficiency.  Lancet . 1968;  2 1366-1369
• 37 Bach F H. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome.  Lancet . 1968;  2 1364-1366
• 38 Thomas E D. Allogeneic marrow grafting: a story of man and dog. In: Terasaki PI, ed. History of Transplantation: Thirty-Five Recollections Los Angeles, CA: UCLA Tissue Typing Laboratory 1991: 379-393
• 39 Calne R Y, Sells R A, Pena J R. Induction of immunological tolerance by porcine liver allografts.  Nature . 1969;  223 472-474
• 40 Kamada N, Brons G, Davies H S. Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens.  Transplantation . 1980;  29 429-431
• 41 Kamada N, Davies H S, Roser B. Reversal of transplantation immunity by liver grafting.  Nature . 1981;  292 840-842
• 42 Zimmerman F A, Davies H S, Knoll P P, Gocke J M, Schmidt T. Orthotopic liver allografts in the rat.  Transplantation . 1984;  37 406-410
• 43 Houssin D, Gigou M, Franco D. Specific transplantation tolerance induced by spontaneously tolerated liver allograft in inbred strains of rat.  Transplantation . 1980;  29 418-419
• 44 Engemann R, Ulrichs K, Thiede A, Muller-Ruchholtz W, Hamelmann H. Value of a physiological liver transplant model in rats. Induction of specific graft tolerance in a fully allogeneic strain combination.  Transplantation . 1982;  33 566-568
• 45 Murase N, Kim D G, Todo S. FK 506 suppression of heart and liver allograft rejection II: the induction of graft acceptance in rat.  Transplantation . 1990;  50 739-744
• 46 Murase N, Starzl T E, Tanabe M. Variable chimerism, graft versus host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to Brown-Norway rats.  Transplantation . 1995;  60 158-171
• 47 Bishop G A, Sun J, DeCruz D J. Tolerance to rat liver allografts. III. Donor cell migration and tolerance-associated cytokine production in peripheral lymphoid tissues.  J Immunol . 1996;  156 4925-4931
• 48 Qian S, Demetris A J, Murase N, Rao A S, Fung J J, Starzl T E. Murine liver allograft transplantation: tolerance and donor cell chimerism.  Hepatology . 1994;  19 916-924
• 49 Lu L, Woo J, Rao A S. Propagation of dendritic cell progenitors from normal mouse liver using GM-CSF and their maturational development in the presence of type-I collagen.  J Exp Med . 1994;  179 1823-1834
• 50 Dahmen U, Qian S, Rao A S. Split tolerance induced by orthotopic liver transplantation in mice.  Transplantation . 1994;  58 1-8
• 51 Lu L, Rudert W A, Qian S. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor.  J Exp Med . 1995;  182 379-387
• 52 Rastellini C, Lu L, Ricordi C. GM-CSF stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival.  Transplantation . 1995;  60 1366-1370
• 53 Qian S, Lu L, Fu F. Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction.  J Immunol . 1997;  158 4654-4661
• 54 Khanna A, Moreli A F, Zhong C. Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo.  J Immunol . 2000;  164 1346-1354
• 55 Davies H S, Kamada N, Roser B J. Mechanisms of donor-specific unresponsiveness induced by liver grafting.  Transplant Proc . 1983;  15 831-835
• 56 Crispe N, Mehal W Z. Strange brew: T cells in the liver.  Immunology Today . 1996;  17 522-525
• 57 Singh P B, Brown R F, Roser B J. Class I transplantation antigens in solution in body fluids and in the urine.  J Exp Med . 1988;  168 195
• 58 Sumimoto R, Kamada N. Specific suppression of allograft rejection by soluble class I antigen and complexes with monoclonal antibody.  Transplantation . 1990;  50 678-682
• 59 Davies H S, Pollard S G, Calne R Y. Soluble HLA antigens in the circulation of liver graft recipients.  Transplantation . 1989;  47 524-527
• 60 Calne R, Davies H. Organ graft tolerance: the liver effect.  Lancet . 1994;  343 67-68
• 61 Calne R Y, Watson C JE, Brons I GM. Tolerance of porcine renal allografts induced by donor spleen cells and seven days' treatment with cyclosporine.  Transplantation . 1994;  57 1433-1435
• 62 Qian S, Fu F, Li Y. Presensitization by skin grafting from MHC class I or class II deficient mice identifies class I antigens as inducers of allosensitization.  Immunology . 1995;  85 82-87
• 63 Corry R J, Winn H J, Russell P S. Primary vascularized allografts of hearts in mice. The role of H-2D, H-2K and non-H-2 antigens in rejection.  Transplantation . 1973;  16 343-350
• 64 Russell P S, Chase C M, Colvin R B, Plate J MD. Kidney transplants in mice: an analysis of the immune status of mice bearing long-term H-2 incompatible transplants.  J Exp Med . 1978;  147 1449-1468
• 65 Schwartz R, Damashek W. Drug induced immunologic tolerance.  Nature (London) . 1959;  183 1682-1683
• 66 Simonsen M. On the acquisition of tolerance by adult cells.  Ann NY Acad Sci . 1960;  87 382-390
• 67 Sterzl J, Silverstein A M. Development aspects of immunity.  Adv Immunol . 1967;  6 337-459
• 68 Dresser D W, Mitchison N A. The mechanism of immunological paralysis.  Adv Immunol . 1998;  8 129-181
• 69 Starzl T E. Host Graft Adaptation. In: Experience in Renal Transplantation Philadelphia: WB Saunders 1964: 168-170
• 70 Starzl T E, Demetris A J, Trucco M. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance.  Hepatology . 1993;  17 1127-1152
• 71 Ramos H C, Reyes J, Abu-Elmagd K. Weaning of immunosuppression in long term liver transplant recipients.  Transplantation . 1995;  59 212-217
• 72 Mazariegos G V, Reyes J, Marino I. Weaning of immunosuppression in liver transplant recipients.  Transplantation . 1997;  63 243-249
• 73 Starzl T E. Efforts to mitigate or prevent rejection: In: Experience in Hepatic Transplantation.  Philadelphia: WB Saunders 1969: 228-233
• 74 Steinman R M, Cohn Z A. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution.  J Exp Med . 1973;  137 1142-1162
• 75 Steinmuller D. Immunization with skin isografts taken from tolerant mice.  Science . 1967;  158 127-129
• 76 Elkins W L, Guttmann R D. Pathogenesis of a local graft versus host reaction: immunogenicity of circulating host leukocytes.  Science . 1968;  159 1250-1251
• 77 Talmage D W, Dart G, Radovich J, Lafferty K J. Activation of transplant immunity: effect of donor leukocytes on thyroid allograft rejection.  Science . 1976;  191 385-387
• 78 Lafferty K J, Prowse S J, Simeonovic C J. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept.  Ann Rev Immunol . 1983;  1 143-173
• 79 Lechler R I, Batchelor J R. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor-strain dendritic cells.  J Exp Med . 1982;  155 31-41
• 80 Kashiwagi N, Porter K A, Penn I, Brettschneider L, Starzl T E. Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver.  Surg Forum . 1969;  20 374-376
• 81 Iwaki Y, Starzl T E, Yagihashi A. Replacement of donor lymphoid tissue in human small bowel transplants under FK 506 immunosuppression.  Lancet . 1991;  337 818-819
• 82 Starzl T E, Demetris A J, Murase N. Cell migration, chimerism, and graft acceptance.  Lancet . 1992;  339 1579-1582
• 83 Starzl T E, Demetris A J, Trucco M. Systemic chimerism in human female recipients of male livers.  Lancet . 1992;  340 876-877
• 84 Starzl T E, Demetris A J, Trucco M. Chimerism after liver transplantation for type IV glycogen storage disease and Type I Gaucher's disease.  N Engl J Med . 1993;  328 745-749
• 85 Starzl T E, Demetris A J, Trucco M. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation.  Transplantation . 1993;  55 1272-1277
• 86 Webb S, Morris C, Sprent J. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity.  Cell . 1990;  63 1249-1256
• 87 Matzinger P. Tolerance, danger, and the extended family.  Ann Rev Immunol . 1994;  12 991-1045
• 88 Moskophidis D, Lechner F, Pircher H, Zinkernagel R M. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells.  Nature . 1993;  362 758-761
• 89 Critchfield J, Racke M, Zuniga-Pflucker J. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis.  Science . 1994;  263 1139-1143
• 90 Aichele P, Brduscha-Riem K, Zinkernagel R M, Hengartner H, Pircher H. T cell priming versus T cell tolerance induced by synthetic peptides.  J Exp Med . 1995;  182 261-266
• 91 Hotchin J. Biology of lymphocytic choriomeningitis infection: Virus induced immune disease.  Cold Spr Harbor Symp Quantitative Biology . 1962;  37 479-499
• 92 Ridge J P, Fuchs E J, Matzinger P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells.  Science . 1996;  271 1723-1726
• 93 Lu L, Li W, Zong C. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.  Transplantation . 1999;  68 747-757
• 94 Murase N, Starzl T E, Ye Q. Multilineage hematopoietic reconstitution of supralethally irradiated rats by syngeneic whole organ transplantation: with particular reference to the liver.  Transplantation . 1996;  61 1-4
• 95 Taniguchi H, Toyoshima T, Fukao K, Nakauchi H. Presence of hematopoietic stem cells in the adult liver.  Nature Medicine . 1996;  2 198-203
• 96 Demetris A J, Murase N, Fujisaki S. Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation.  Transpl Proc . 1993;  25 3337-3344
• 97 Murase N, Demetris A J, Woo J. Lymphocyte traffic and graft-versus-host disease after fully allogeneic small bowel transplantation.  Transpl Proc . 1991;  23 3246-3247
• 98 Demetris A J, Murase N, Starzl T E. Donor dendritic cells after liver and heart allotransplantation under short-term immunosuppression.  Lancet . 1992;  339 1610
• 99 Steinman R M. The dendritic cell system and its role in immunogenicity.  Annu Rev Immunol . 1991;  9 271-296
• 100 Thomson A W, Lu L, Murase N. Microchimerism, dendritic cell progenitors and transplantation tolerance.  Stem Cells . 1995;  13 622-639
• 101 Rudert W A, Kocova M, Rao A, Trucco M. Fine quantitation by competitive PCR of circulating donor cells in post-transplanted chimeric recipients.  Transplantation . 1994;  58 964-965
• 102 Hisanaga M, Hundrieser J, Boker K. Development, stability, and clinical correlations of allogeneic microchimerism after solid organ transplantation.  Transplantation . 1996;  61 40-45
• 103 Murase N, Demetris A J, Tsamandas A C, Ye Q, Starzl T E. The heterogenous distribution of chimerism produced by rat organ and bone marrow allotransplantation.  Transplantation . 1996;  61 1126-1131
• 104 Ichikawa N, Demetris A J, Starzl T E. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection.  Liver Transplant . 2000;  6 686-702
• 105 Sakamoto T, Ye Q, Lu L. Donor hematopoietic progenitor cells in nonmyeloablated rat recipients of allogeneic bone marrow and liver grafts.  Transplantation . 1999;  67 833-840
• 106 Starzl T E, Demetris A J. Transplantation milestones: viewed with one- and two-way paradigms of tolerance.  JAMA . 1995;  273 876-879
• 107 Przepiorka D, Thomas E D, Durham D M, Fisher L. Use of a probe to repeat sequence of the Y chromosome for detection of host cells in peripheral blood of bone marrow transplant recipients.  Am J Clin Pathol . 1991;  95 201-206
• 108 Wessman M, Popp S, Ruutu T. Detection of residual host cells after bone marrow transplantation using non-isotopic in situ hyubridization and karyotype analysis.  Bone Marrow Transplant . 1993;  11 279-284
• 109 Starzl T E, Zinkernagel Z R. Antigen localization and migration in immunity and tolerance.  N Eng J Med . 1998;  339 1905-1913
• 110 Starzl T E, Rao A S, Trucco M. Explanation for loss of the HLA matching effect.  Transplant Proc . 1995;  27 57-60
• 111 Markus B H, Duquesnoy R J, Gordon R D. Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect?.  Transplanttaion . 1998;  46 372-377
• 112 Donaldson P, Underhill J, Doherty D. Influence of human leukocyte antigen matching on liver allograft survival and rejection: ``the dualistic effect''.  Hepatology . 1993;  17 1008-1015
• 113 Fontes P, Rao A, Demetris J A, Zeevi A. Augmentation with bone marrow of donor leukocyte migration for kidney, liver, heart, and pancreas islet transplantation.  Lancet . 1994;  344 151-155
• 114 Rao A S, Fontes P, Dodson F. Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients.  Transplant Proc . 1996;  28 2959-2965
• 115 Garcia Morales R, Esquenazi V, Zucker K. Assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry (PCR-FLOW).  Transplantation . 1996;  62 1149-1160
• 116 Zinkernagel R M. Immunology taught by viruses.  Science . 1996;  271 173-178
• 117 Zinkernagel R M, Ehl S, Aichele P. Antigen localization regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity.  Immunol Reviews . 1997;  156 199-209
• 118 Zinkernagel R M, Bachmann M F, Kundig T M. On immunological memory.  Ann Rev Immunol . 1996;  14 333-367
• 119 Doherty P C, Zinkernagel R M. A biological role for the major histocompatibility antigens.  Lancet . 1975;  2 1406-1409
• 120 Zinkernagel R M, Doherty P C. The discovery of MHC restriction.  Immunology Today . 1997;  18 14-17
• 121 Nemlander A, Soots A, von Willebrand E, Husberg B, Hayry P. Redistribution of renal allograft-responding leukocytes during rejection. II. Kinetics and specificity.  J Exp Med . 1982;  156 1087-1100
• 122 Larsen C P, Morris P J, Austyn J M. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel route for initiation of rejection.  J Exp Med . 1990;  171 307-314
• 123 Demetris A J, Qian S, Sun H. Early events in liver allograft rejection: delineation of sites simultaneous intragraft and recipient lymphoid tissue sensitization.  Am J Pathol . 1991;  138 609-618
• 124 Zinkernagel R M, Hengartner H. Antiviral immunity.  Immunology Today . 1997;  18 258-260
• 125 Lenardo M, Chan F K, Hornung F. Mature lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigen environment.  Ann Rev Immunol . 1999;  17 221-253
• 126 Li Y, Li X C, Zheng X X. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance.  Nature Medicine . 1999;  5 1298-1302
• 127 Wells A D, Li X C, Li Y. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance.  Nature Medicine . 1999;  5 1303-1307
• 128 Wood K, Sachs D H. Chimerism and transplantation tolerance: cause and effect.  Immunol Today . 1996;  17 584-587
• 129 Terakura M, Murase N, Demetris A J. Lymphoid/nonlymphoid compartmentalization of donor leukocyte chimerism in rat recipients of heart allografts, with or without adjunct bone marrow.  Transplantation . 1998;  66 350-357
• 130 Ohashi P S, Oehen S, Buerki K. Ablation of ``tolerance'' and induction of diabetes by viruses infection in viral antigen transgenic mice.  Cell . 1991;  65 305-317
• 131 Ohashi P S, Oehen S, Aichele P. Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-α.  J Immunol . 1993;  150 5185-5194
• 132 Ko S, Deiwick A, Jager M D. The functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat.  Nature Medicine . 1999;  5 1292-1297
• 133 Ehl S, Aichele P, Ramseier H. Antigen persistence and time of T-cell tolerization determine the efficacy of tolerization protocols for prevention of skin graft rejection.  Nat Med . 1998;  4 1015-1019
• 134 Salgar S, Shapiro R, Dodson F. Infusion of donor leukocytes to induce tolerance in organ allograft recipients.  J Leukoc Biol . 1999;  66 310-314
• 135 Hart D NJ, Winearls C G, Fabre J W. Graft adaptation: studies on possible mechanisms in long-term surviving rat renal allografts.  Transplantation . 1980;  30 73-80
• 136 Thai N L, Qian T S, Fu F. Mouse liver transplantation tolerance: the role of hepatocytes and nonparenchymal cells.  Transplant Proc . 1995;  27 509-510
• 137 Sriwatanawongsa V, Davies H S, Calne R Y. The essential roles of parenchymal tissues and passenger leukocytes in the tolerance induced by liver grafting in rats.  Nat Med . 1995;  1 428-432
• 138 Bumgardner G L, Li J, Heininger M, Orosz C G. Costimulation pathways in host immune responses to allogeneic hepatocytes.  Transplantation . 1998;  66 1841-1845
• 139 Bumgardner G L, Heininger M, Li J. A functional model of hepatocyte transplantation for in vivo immunologic studies.  Transplantation . 1998;  65 53-61
• 140 Bumgardner G L, Li J, Heininger M, Ferguson R M, Orosz C G. In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model.  Transplantation . 1998;  65 47-52